Literature DB >> 33849070

Global RNA profiles show target selectivity and physiological effects of peptide-delivered antisense antibiotics.

Linda Popella1, Jakob Jung1, Kristina Popova1, Svetlana Ðurica-Mitić1, Lars Barquist2,3, Jörg Vogel1,2,3.   

Abstract

Antisense peptide nucleic acids (PNAs) inhibiting mRNAs of essential genes provide a straight-forward way to repurpose our knowledge of bacterial regulatory RNAs for development of programmable species-specific antibiotics. While there is ample proof of PNA efficacy, their target selectivity and impact on bacterial physiology are poorly understood. Moreover, while antibacterial PNAs are typically designed to block mRNA translation, effects on target mRNA levels are not well-investigated. Here, we pioneer the use of global RNA-seq analysis to decipher PNA activity in a transcriptome-wide manner. We find that PNA-based antisense oligomer conjugates robustly decrease mRNA levels of the widely-used target gene, acpP, in Salmonella enterica, with limited off-target effects. Systematic analysis of several different PNA-carrier peptides attached not only shows different bactericidal efficiency, but also activation of stress pathways. In particular, KFF-, RXR- and Tat-PNA conjugates especially induce the PhoP/Q response, whereas the latter two additionally trigger several distinct pathways. We show that constitutive activation of the PhoP/Q response can lead to Tat-PNA resistance, illustrating the utility of RNA-seq for understanding PNA antibacterial activity. In sum, our study establishes an experimental framework for the design and assessment of PNA antimicrobials in the long-term quest to use these for precision editing of microbiota.
© The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Year:  2021        PMID: 33849070     DOI: 10.1093/nar/gkab242

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  4 in total

1.  Oligonucleotide Solid Nucleolipid Nanoparticles against Antibiotic Resistance of ESBL-Producing Bacteria.

Authors:  Phuoc Vinh Nguyen; Clémentine Aubry; Narimane Boudaoud; Alexandra Gaubert; Marie-Hélène Langlois; Mathieu Marchivie; Karen Gaudin; Corinne Arpin; Philippe Barthélémy; Tina Kauss
Journal:  Pharmaceutics       Date:  2022-01-27       Impact factor: 6.321

2.  Robust Acquisition of Spatial Transcriptional Programs in Tissues With Immunofluorescence-Guided Laser Capture Microdissection.

Authors:  Xiaodan Zhang; Chuansheng Hu; Chen Huang; Ying Wei; Xiaowei Li; Miaomiao Hu; Hua Li; Ji Wu; Daniel M Czajkowsky; Yan Guo; Zhifeng Shao
Journal:  Front Cell Dev Biol       Date:  2022-03-25

3.  An Efficient Approach for the Design and Synthesis of Antimicrobial Peptide-Peptide Nucleic Acid Conjugates.

Authors:  Nitin A Patil; Varsha J Thombare; Rong Li; Xiaoji He; Jing Lu; Heidi H Yu; Hasini Wickremasinghe; Kavya Pamulapati; Mohammad A K Azad; Tony Velkov; Kade D Roberts; Jian Li
Journal:  Front Chem       Date:  2022-03-15       Impact factor: 5.221

4.  Smart therapies against global pandemics: A potential of short peptides.

Authors:  Vasso Apostolopoulos; Joanna Bojarska; Jack Feehan; John Matsoukas; Wojciech Wolf
Journal:  Front Pharmacol       Date:  2022-08-15       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.